A study has shown that unlike opioids like morphine, the experimental painkiller does not cause tolerance, meaning you don't ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

LOS ANGELES, CA - January 15, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has released ...

Opioid agonist/antagonist has a big impact in phase IIb trial ...

Infants exposed to opioids and psychotropic drugs during pregnancy have a 30% to 60% higher risk of experiencing neonatal withdrawal, a study has found. That risk doubles when multiple psychotropic ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx works ...

Costa Mesa is set to receive $4.6 million over 15 years as part of the nationwide legal settlements against drug makers and ...

A clinical trial of an experimental drug for treatment-resistant major depression finds that modulation of the endogenous opioid system may improve the effectiveness of drugs that target the action of ...

As more Americans receive treatment for opioid-use disorder, that progress is increasingly showing up in the operating room, ...

There is a black market for buprenorphin, an approved drug for opioid addiction. This is a Kaiser Health News story. Months in prison didn’t rid Daryl of his addiction to opioids. “Before I left the ...